Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
ANUH PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -19.2051.689.98-5.38102.79

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is -19.20 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-19.20
Mar202451.68
Mar20239.98
Mar2022-5.38
Mar2021102.79

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -19.2
Negative
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38
Negative
Mar2021 102.79 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹814.1 Cr -1.8% 5.7% -6.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,497.0 Cr -1.4% -6.2% -1.6% Stock Analytics
DIVIS LABORATORIES ₹166,939.0 Cr -0.1% 2.3% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,109.0 Cr -1.8% -4.9% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,578.0 Cr -0.4% -6% 5.3% Stock Analytics
CIPLA ₹99,761.1 Cr 0.4% -2.6% -17.6% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-1.8%

5.7%

-6.7%

SENSEX

0.5%

3.2%

2.3%


You may also like the below Video Courses